NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...
Last week, the Securities and Exchange Commission (SEC) announced two enforcement actions related to the failed implementation of anti-money-laundering (AML) procedures. These charges reflect the ...
In this retrospective study, researchers stratified pediatric AML patients by risk and aimed to determine whether some could receive fewer chemotherapy cycles without affecting relapse and survival ...
Median Overall Survival (OS) of 15 months for subjects with complete remission (n=8) Median OS of 2 nd Line efficacy evaluable population of 12 months (n=9) Median OS of Intent to Treat population (1L ...
Cryptopolitan on MSN
Canada as an ideal FinTech launchpad and AML Incubator’s enabling role
In this article, we examine why Canada has become a strategic launchpad for FinTech and crypto founders, and how executive teams can leverage AML Incubator to ...
Revumenib demonstrates significant efficacy in R/R AML with NPM1m, KMT2Ar, and NUP98r, showing high response rates and tolerability. The AUGMENT-101 study reports a 26% CR/CRh rate in NPM1-mutated AML ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback